Nature of the renal concentrating defect in sickle cell disease
- PMID: 6023770
- PMCID: PMC297054
- DOI: 10.1172/JCI105535
Nature of the renal concentrating defect in sickle cell disease
Abstract
Free water reabsorption (T(c) (H2O)) measured during 10% mannitol diuresis and subsequently during 3% saline diuresis was compared in patients with sickle cell anemia and in normal subjects. During mannitol infusion, T(c) (H2O) progressively rose with increasing osmolar clearance (C(osm)) and reached a maximal level in both groups studied. During hypertonic saline diuresis, T(c) (H2O) progressively rose in the normal subjects and exceeded the maximal levels attained during mannitol diuresis, with no evidence of a maximal T(c) (H2O) level appearing. In contrast, none of the saline curves significantly exceeded the mannitol curves in the sickle cell patients but tended to parallel the mannitol curves at comparable rates of solute clearance. Since T(c) (H2O) is an index of both solute (sodium) transport from the loop of Henle and solute accumulation in the hypertonic medullary interstitium, tubular sodium handling was examined in both sickle cell patients and control subjects alike. No difference in the tubular transport of sodium could be demonstrated either under conditions of sodium loading or under conditions in which the tubular sodium load was low (water diuresis). These data support the conclusion that the defect in urinary concentration in sickle cell patients is caused by a limitation in maintaining a high concentration of solute in the medullary interstitium, thus limiting the rate of T(c) (H2O) from the collecting duct.
Similar articles
-
Urine concentration during solute diuresis in potassium-depleted rabbits. Evidence for a defect in tubular sodium transport.J Physiol. 1971 Feb;212(3):763-75. doi: 10.1113/jphysiol.1971.sp009355. J Physiol. 1971. PMID: 5557070 Free PMC article.
-
Mechanism of exaggerated natriuresis in hypertensive man: impaired sodium transport in the loop of Henle.J Clin Invest. 1969 Jun;48(6):1007-16. doi: 10.1172/JCI106057. J Clin Invest. 1969. PMID: 5771185 Free PMC article.
-
Evidence against bicarbonate reabsorption in the ascending limb, particularly as disclosed by free-water clearance studies.Yale J Biol Med. 1975 Sep;48(4):337-47. Yale J Biol Med. 1975. PMID: 1202762 Free PMC article.
-
Osmotic diuresis.Ren Physiol. 1987;10(3-4):160-73. doi: 10.1159/000173127. Ren Physiol. 1987. PMID: 3133729 Review.
-
The natural history of sickle cell disease.Ann N Y Acad Sci. 1989;565:104-8. doi: 10.1111/j.1749-6632.1989.tb24156.x. Ann N Y Acad Sci. 1989. PMID: 2672960 Review. No abstract available.
Cited by
-
Management of sickle cell disorders.Proc R Soc Med. 1974 Oct;67(10):1073-5. doi: 10.1177/003591577406701049. Proc R Soc Med. 1974. PMID: 4427910 Free PMC article. No abstract available.
-
Dysnatremias in patients with kidney disease.Am J Kidney Dis. 2014 Feb;63(2):294-303. doi: 10.1053/j.ajkd.2013.09.017. Epub 2013 Nov 14. Am J Kidney Dis. 2014. PMID: 24239050 Free PMC article. Review.
-
Elimination of the fibrinogen integrin αMβ2-binding motif improves renal pathology in mice with sickle cell anemia.Blood Adv. 2019 May 14;3(9):1519-1532. doi: 10.1182/bloodadvances.2019032342. Blood Adv. 2019. PMID: 31076408 Free PMC article.
-
Urine concentrating ability in infants with sickle cell disease: baseline data from the phase III trial of hydroxyurea (BABY HUG).Pediatr Blood Cancer. 2010 Feb;54(2):265-8. doi: 10.1002/pbc.22189. Pediatr Blood Cancer. 2010. PMID: 19621454 Free PMC article.
-
Endothelin receptor antagonists in sickle cell disease: A promising new therapeutic approach.Life Sci. 2016 Aug 15;159:15-19. doi: 10.1016/j.lfs.2016.04.001. Epub 2016 Apr 3. Life Sci. 2016. PMID: 27049871 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources